Sparc-like protein 1 is a new marker of human glioma progression.

作者: Andrei Turtoi , Davide Musmeci , Antonio Giuseppe Naccarato , Cristian Scatena , Valerio Ortenzi

DOI: 10.1021/PR3005698

关键词: ExtracellularSPARC-Like Protein 1BiologyProteomicsImmunologyCancerGliomaProteomeMembrane proteinBiotinylationCancer research

摘要: High-grade gliomas (glioblastomas) are the most common and deadly brain tumors in adults, currently with no satisfactory treatment available. Apart from de novo glioblastoma, it is accepted that these malignancies mainly progress lower grade glial tumors. However, molecular entities governing progression of poorly understood. Extracellular membrane proteins key biomolecules found at cell-to-cell communication interface hence a promising proteome subpopulation could help understand development glioma. Accordingly, current study aims identifying new protein markers human glioma progression. For this purpose, we used generated orthotopically T98G U373 cells nude mice. This setup allowed also to discriminate origin, namely, (tumor) or mouse (host). were selectively purified using biotinylation followed by streptavidin affinity chromatography. Isolated digested then identified quantified employing 2D- nano-HPLC−MS/MS analysis. A total 23 27 up- regulated extracellular models, respectively. Approximately two-thirds predominantly produced tumor, whereas remaining appeared be overexpressed host tissue. Following extensive validation, have focused our attention on sparc-like 1. was further investigated immunohis- tochemistry large collection samples different grades. The results showed 1 expression correlates grade, suggesting possible role for malignancy.

参考文章(43)
Akeila Bellahcene, Vincenzo Castronovo, Increased Expression of Osteonectin and Osteopontin, Two Bone Matrix Proteins, in Human Breast Cancer American Journal of Pathology. ,vol. 146, pp. 95- 100 ,(1995)
Hiroko Ohgaki, Epidemiology of brain tumors. Methods of Molecular Biology. ,vol. 472, pp. 323- 342 ,(2009) , 10.1007/978-1-60327-492-0_14
Göran Hesselager, Lene Uhrbom, Bengt Westermark, Monica Nistér, Glial tumors of the CNS Oxford University Press. ,vol. 2, pp. 437- ,(2001)
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
A Claeskens, N Ongenae, J M Neefs, P Cheyns, P Kaijen, M Cools, E Kutoh, Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. British Journal of Cancer. ,vol. 82, pp. 1123- 1130 ,(2000) , 10.1054/BJOC.1999.1051
Gabriel Iacob, Eduard B Dinca, Current data and strategy in glioblastoma multiforme Journal of medicine and life. ,vol. 2, pp. 386- 393 ,(2009)
Ping Li, Jianxin Qian, Guanzhen Yu, Ying Chen, Ke Liu, Jie Li, Jiejun Wang, Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer. Journal of Surgical Oncology. ,vol. 105, pp. 31- 37 ,(2012) , 10.1002/JSO.22025
Peter Schraml, Igor Bendik, Christian U. Ludwig, Characterization of MAST9/Hevin, a SPARC-like Protein, That is Down-Regulated in Non-Small Cell Lung Cancer Cancer Research. ,vol. 58, pp. 626- 629 ,(1998)
Tercia Rodrigues Alves, Flavia Regina Souza Lima, Suzana Assad Kahn, Denise Lobo, Luiz Gustavo Feijó Dubois, Rossana Soletti, Helena Borges, Vivaldo Moura Neto, None, Glioblastoma cells: a heterogeneous and fatal tumor interacting with the parenchyma. Life Sciences. ,vol. 89, pp. 532- 539 ,(2011) , 10.1016/J.LFS.2011.04.022
CP-Y Lau, RT-P Poon, S-T Cheung, W-C Yu, S-T Fan, SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. The Journal of Pathology. ,vol. 210, pp. 459- 468 ,(2006) , 10.1002/PATH.2068